Jaguar动物健康 JAGX 深 沪
已收盘 01-30 16:00:00 美东时间
0.6746
-0.016
-2.39%
华盛通- 最 高0.70
- 今 开0.695
- 成交量 34.16万股
- 最 低 0.66
- 昨 收 0.6911
- 总市值 252.02万
- 52周最高 25.75
- 市盈率 静 --
- 换手率 9.14%
- 52周最低 0.6401
- 委 比 -22.68%
- 总股本 373.58万
- 历史最高 2501887500.00
- 量 比 0.36
- 振 幅 5.79%
- 历史最低 0.6401
- 每 手 1
- 风险率 5.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jaguar Health Reduces Debt Through Equity Exchange with Iliad
Jaguar Health Reduces Debt Through Equity Exchange with Iliad Jaguar Health Inc. announced it has entered into privately negotiated exchange agreements with Iliad Research and Trading, L.P. and Streeterville, involving the exchange of outstanding royalty interests and preferred stock for pre-funded
01-26 15:44
Jaguar Health Executes Debt-Reducing Equity Warrant Transactions
An update from Jaguar Animal Health ( ($JAGX) ) is now available. On January 16...
01-24 06:26
Why Rapt Therapeutics Shares Are Trading Higher By 63%; Here Are 20 Stocks Moving Premarket
Shares of Rapt Therapeutics Inc (NASDAQ:RAPT) rose sharply in pre-market tradin...
01-20 18:02
The Surge In Jaguar Health Stock: What's Happening Now?
Jaguar Health Inc (NASDAQ:JAGX) subsidiary, Napo Pharmaceuticals, has struck a new licensing deal with Woodward Specialty.
01-17 02:54
Jaguar Health Subsidiary Signs Licensing Agreement With Future Pak Affiliate For Exclusive Marketing Of Mytesi Drug
Jaguar Health, Inc. (NASDAQ:JAGX) today announced that its wholly-owned subsidiary Napo Pharmaceuticals, Inc. (collectively, with Jaguar Health, Inc., "Jaguar") has entered into a U.S. licensing agreement with an
01-12 22:05
Jaguar Animal Health Raises Short-Term Capital Through Notes
Jaguar Animal Health ( ($JAGX) ) has issued an update. On January 6, 2026, Jagu...
01-12 19:32
Jaguar Health Awarded $240K Grant From FAD's Center For Veterinary Medicine
Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that it received notice from the U.S. Food and Drug Administration's Center for Veterinary Medicine (CVM) on January 1, 2026 that the company has been awarded
01-02 22:04
Jaguar Health Executes Strategic Stock Exchange Agreements
Jaguar Animal Health ( ($JAGX) ) has shared an update. On June 27, 2025, Jaguar...
2025-12-13 06:20
Jaguar Health's Napo Therapeutics Requests Advice From EMA's CVMP Regarding Its Plan To Pursue Approval Of Canalevia In EU For Treatment Of General Diarrhea In Dogs
Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia®A novel non-antibiotic approach to diarrhea treatment is important because there are no
2025-12-02 22:05
Jaguar Health Submits All Amended Protocol To FDA For Its Current Clinical Studies Of Crofelemer In Pediatric MVID Participants
Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that, in support of a possible expedited approval pathway for crofelemer for treatment of intestinal failure in
2025-11-20 22:04
